193 related articles for article (PubMed ID: 20618824)
1. Triptans, SSRIs/SNRIs and serotonin syndrome.
Rothrock JF
Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
[No Abstract] [Full Text] [Related]
2. Triptans and serotonin syndrome.
Fine A; Bastings E
Headache; 2012; 52(7):1184-5; author reply 1185-8. PubMed ID: 22755550
[No Abstract] [Full Text] [Related]
3. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Evans RW; Tepper SJ; Shapiro RE; Sun-Edelstein C; Tietjen GE
Headache; 2010 Jun; 50(6):1089-99. PubMed ID: 20618823
[TBL] [Abstract][Full Text] [Related]
4. From the editorial office.
Rothrock JF
Headache; 2012; 52(7):1069. PubMed ID: 22755549
[No Abstract] [Full Text] [Related]
5. Triptans and serotonin syndrome.
Evans RW
Cephalalgia; 2008 May; 28(5):573-4; author reply 574-5. PubMed ID: 18355351
[No Abstract] [Full Text] [Related]
6. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Orlova Y; Rizzoli P; Loder E
JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
[TBL] [Abstract][Full Text] [Related]
7. Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
Bonetto N; Santelli L; Battistin L; Cagnin A
Cephalalgia; 2007 Dec; 27(12):1421-3. PubMed ID: 17868285
[No Abstract] [Full Text] [Related]
8. Drug interactions with triptans : which are clinically significant?
Rolan PE
CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
[TBL] [Abstract][Full Text] [Related]
9. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
Tepper SJ
Headache; 2012 Feb; 52(2):195-7. PubMed ID: 22221260
[No Abstract] [Full Text] [Related]
10. Is an FDA alert harming patients?
Schuman E
JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
[No Abstract] [Full Text] [Related]
11. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports.
Evans RW
MedGenMed; 2007 Sep; 9(3):48. PubMed ID: 18092054
[TBL] [Abstract][Full Text] [Related]
12. Do triptan antimigraine medications interact with SSRI/SNRI antidepressants? What does your decision support system say?
Kogut SJ
J Manag Care Pharm; 2011 Sep; 17(7):547-51. PubMed ID: 21870895
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?
Mansuri Z; Adnan M; Shah B; Trivedi C; Vadukapuram R; Patel S; Yadav G; Srinivas S; Ansari M; Makani R; Baweja R; Reddy A
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):199-200. PubMed ID: 38227629
[No Abstract] [Full Text] [Related]
14. Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report.
Meng Y; Yuen J
J Pharm Pract; 2023 Jun; 36(3):705-710. PubMed ID: 34962845
[No Abstract] [Full Text] [Related]
15. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.
Gillman PK
Headache; 2010 Feb; 50(2):264-72. PubMed ID: 19925619
[TBL] [Abstract][Full Text] [Related]
16. Serotonin syndrome and the use of SSRIs.
Finfgeld DL
J Psychosoc Nurs Ment Health Serv; 2004 Feb; 42(2):16-20. PubMed ID: 14982105
[TBL] [Abstract][Full Text] [Related]
17. The serotonin syndrome, triptans, and the potential for drug-drug interactions.
Shapiro RE; Tepper SJ
Headache; 2007 Feb; 47(2):266-9. PubMed ID: 17300366
[TBL] [Abstract][Full Text] [Related]
18. Concomitant triptan and SSRI or SNRI use: what is the risk for serotonin syndrome?
Evans RW
Headache; 2008 Apr; 48(4):639-40. PubMed ID: 18377388
[No Abstract] [Full Text] [Related]
19. Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.
Boutilier AS; Gardner DM
J Clin Pharm Ther; 2003 Feb; 28(1):69-72. PubMed ID: 12605621
[No Abstract] [Full Text] [Related]
20. Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary.
Horn JR; Hansten PD
J Manag Care Pharm; 2011 Nov; 17(9):713. PubMed ID: 22050397
[No Abstract] [Full Text] [Related]
[Next] [New Search]